ReviewFrontiers in oncology2022
Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers.
Hayle Scanlan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Hayle Scanlan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.